Growth Metrics

NovoCure (NVCR) EBITDA Margin Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -430.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 128.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -361.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 141.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 102.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 58.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 851.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -313.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 535.00
10 NovoCure 1.90 Bn 1.47 Bn 135.13 Mn -1,430.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1,430.00
Dec 31, 2025 1,609.00
Sep 30, 2025 -85.00
Jun 30, 2025 -255.00
Mar 31, 2025 555.00
Dec 31, 2024 -60.00
Sep 30, 2024 2,505.00
Jun 30, 2024 2,738.00
Mar 31, 2024 1,933.00
Dec 31, 2023 -519.00
Sep 30, 2023 -2,696.00
Jun 30, 2023 -3,471.00
Mar 31, 2023 -4,872.00
Dec 31, 2022 -1,590.00
Sep 30, 2022 -1,239.00
Jun 30, 2022 -579.00
Mar 31, 2022 -52.00
Dec 31, 2021 -2,596.00
Sep 30, 2021 -1,772.00
Jun 30, 2021 -1,496.00
Mar 31, 2021 325.00
Dec 31, 2020 825.00
Sep 30, 2020 714.00
Jun 30, 2020 437.00
Mar 31, 2020 503.00
Dec 31, 2019 1,259.00
Sep 30, 2019 1,229.00
Jun 30, 2019 1,290.00
Mar 31, 2019 1,597.00
Dec 31, 2018 -404.00
Sep 30, 2018 371.00
Jun 30, 2018 2,895.00
Mar 31, 2018 1,402.00
Dec 31, 2017 5,072.00
Sep 30, 2017 11,860.00
Jun 30, 2017 16,734.00
Mar 31, 2017 20,634.00
Dec 31, 2016 18,805.00
Sep 30, 2016 12,954.00
Jun 30, 2016 20,800.00
Mar 31, 2016 17,671.00
Dec 31, 2015 35,818.00
Sep 30, 2015 14,940.00